ZA979011B - Hormonal composition and its use. - Google Patents

Hormonal composition and its use.

Info

Publication number
ZA979011B
ZA979011B ZA9709011A ZA979011A ZA979011B ZA 979011 B ZA979011 B ZA 979011B ZA 9709011 A ZA9709011 A ZA 9709011A ZA 979011 A ZA979011 A ZA 979011A ZA 979011 B ZA979011 B ZA 979011B
Authority
ZA
South Africa
Prior art keywords
hormonal composition
hormonal
composition
Prior art date
Application number
ZA9709011A
Other languages
English (en)
Inventor
Michel Lanquetin
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9496456&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA979011(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Publication of ZA979011B publication Critical patent/ZA979011B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/811Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
ZA9709011A 1996-10-08 1997-10-08 Hormonal composition and its use. ZA979011B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9612239A FR2754179B1 (fr) 1996-10-08 1996-10-08 Nouvelle composition hormononale et son utilisation

Publications (1)

Publication Number Publication Date
ZA979011B true ZA979011B (en) 1998-06-03

Family

ID=9496456

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9709011A ZA979011B (en) 1996-10-08 1997-10-08 Hormonal composition and its use.

Country Status (38)

Country Link
US (4) US6831073B1 (xx)
EP (2) EP0956022B1 (xx)
JP (1) JP4883542B2 (xx)
KR (2) KR20000048981A (xx)
CN (3) CN101229173A (xx)
AP (1) AP1171A (xx)
AR (2) AR009113A1 (xx)
AT (2) ATE353652T1 (xx)
AU (1) AU745571B2 (xx)
BR (1) BR9712274A (xx)
CA (1) CA2268358C (xx)
CL (1) CL2011000017A1 (xx)
CZ (1) CZ298402B6 (xx)
DE (3) DE69737373T2 (xx)
DK (2) DK1334725T3 (xx)
DZ (1) DZ2327A1 (xx)
ES (2) ES2198006T3 (xx)
FR (2) FR2754179B1 (xx)
HK (1) HK1210708A1 (xx)
HU (2) HU227450B1 (xx)
ID (1) ID21569A (xx)
IL (1) IL129194A (xx)
LU (1) LU91932I2 (xx)
MA (1) MA24370A1 (xx)
MY (1) MY128482A (xx)
NO (3) NO324357B1 (xx)
NZ (1) NZ334876A (xx)
OA (1) OA11033A (xx)
PL (1) PL192979B1 (xx)
PT (2) PT956022E (xx)
RU (1) RU2274450C2 (xx)
SK (2) SK285455B6 (xx)
TN (1) TNSN97164A1 (xx)
TR (1) TR199900764T2 (xx)
TW (1) TW491704B (xx)
WO (1) WO1998015279A1 (xx)
YU (1) YU18099A (xx)
ZA (1) ZA979011B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE19549264A1 (de) * 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
UY29185A1 (es) * 2004-11-02 2006-05-31 Schering Ag Formas de dosificación oral sólidas que contienen una dosis baja de estradiol
PE20081895A1 (es) * 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
KR20240005348A (ko) 2022-07-05 2024-01-12 신규식 소멸특허 관리 및 특허거래 시스템

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3271392A (en) * 1965-09-14 1966-09-06 American Home Prod 17alpha-[3'-furyl]-estrogens
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
JPS61243059A (ja) * 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度4,4′−ジヒドロキシジフエニルスルホンの製造法
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
ZA87332B (en) 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
IE61236B1 (en) 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
EP0309263B1 (en) 1987-09-24 1994-03-09 Jencap Research Limited Hormone composition and use
CA1332227C (en) 1987-09-24 1994-10-04 Robert F. Casper Oral contraceptive formulation
US5256421A (en) * 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
HUT52382A (en) 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US6150343A (en) 1993-06-30 2000-11-21 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en) 1994-09-22 2003-09-02 Board Of Regents, The University Of Texas System Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19540253C2 (de) 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de) 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
AU2815897A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
WO1997041872A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1997041871A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1997041869A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1997041870A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1998004267A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Progestin/estrogen oral contraceptive
WO1998004246A2 (en) 1996-07-26 1998-02-05 American Home Prod Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
DK0917466T3 (da) 1996-07-26 2004-12-20 Wyeth Corp Oralt antikonceptionsmiddel
AU3961697A (en) 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
AU4043597A (en) 1996-07-26 1998-02-20 American Home Products Corporation Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
DE19705229C2 (de) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
PT1007052E (pt) 1997-08-27 2005-01-31 Ortho Mcneil Pharm Inc Combinacoes de progestinas de crescimento do endometrico e progestinas de atropia do endometrio com estrogenios, em contracepcao oral
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
CN1270521A (zh) 1997-09-12 2000-10-18 美国家用产品公司 第一阶段包含孕激素/***并且第二阶段包含孕激素的口服避孕制剂
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Also Published As

Publication number Publication date
AR073972A2 (es) 2010-12-15
PL192979B1 (pl) 2006-12-29
EP1334725A3 (fr) 2004-01-21
US20040220163A1 (en) 2004-11-04
NO991593L (no) 1999-06-07
ID21569A (id) 1999-06-24
SK285455B6 (sk) 2007-01-04
YU18099A (sh) 2002-03-18
NZ334876A (en) 2001-06-29
RU2274450C2 (ru) 2006-04-20
US7749987B2 (en) 2010-07-06
PT1334725E (pt) 2007-05-31
AP9901500A0 (en) 1999-06-30
SK43899A3 (en) 1999-12-10
DK1334725T3 (da) 2007-06-11
PL332610A1 (en) 1999-09-27
JP4883542B2 (ja) 2012-02-22
BR9712274A (pt) 1999-08-31
FR12C0005I2 (fr) 2016-06-24
CZ9901120A3 (cs) 2000-11-15
CN101229173A (zh) 2008-07-30
KR20060084864A (ko) 2006-07-25
ES2198006T3 (es) 2004-01-16
NO991593D0 (no) 1999-03-31
NO2017043I2 (no) 2019-01-25
MY128482A (en) 2007-02-28
FR12C0005I1 (fr) 2012-02-24
DE69737373D1 (de) 2007-03-29
DE69721314D1 (de) 2003-05-28
AU745571B2 (en) 2002-03-21
NO2012002I1 (no) 2012-01-24
TR199900764T2 (xx) 1999-07-21
OA11033A (fr) 2003-03-06
DE122012000010I1 (de) 2012-04-19
IL129194A0 (en) 2000-02-17
DK0956022T3 (da) 2003-08-04
HUP9904508A2 (hu) 2000-06-28
EP1334725B1 (fr) 2007-02-14
TW491704B (en) 2002-06-21
CZ298402B6 (cs) 2007-09-19
ATE353652T1 (de) 2007-03-15
KR20000048981A (ko) 2000-07-25
NO2017043I1 (no) 2017-08-08
AR009113A1 (es) 2000-03-08
HUS1200002I1 (hu) 2016-08-29
NO324357B1 (no) 2007-10-01
AP1171A (en) 2003-06-30
DZ2327A1 (fr) 2002-12-28
CA2268358A1 (fr) 1998-04-16
US6906049B1 (en) 2005-06-14
LU91932I9 (xx) 2018-12-27
AU4627397A (en) 1998-05-05
DE69721314T2 (de) 2004-02-12
EP0956022A1 (fr) 1999-11-17
EP1334725A2 (fr) 2003-08-13
WO1998015279A1 (fr) 1998-04-16
DE69737373T2 (de) 2007-06-21
SK285056B6 (sk) 2006-05-04
FR2754179B1 (fr) 1998-12-24
NO2012002I2 (no) 2013-04-02
HUP9904508A3 (en) 2001-01-29
US6831073B1 (en) 2004-12-14
FR2754179A1 (fr) 1998-04-10
CL2011000017A1 (es) 2011-06-24
MA24370A1 (fr) 1998-07-01
CN104706641A (zh) 2015-06-17
KR100782638B1 (ko) 2007-12-06
EP0956022B1 (fr) 2003-04-23
TNSN97164A1 (fr) 1999-12-31
IL129194A (en) 2003-06-24
US20070281912A1 (en) 2007-12-06
CA2268358C (fr) 2010-04-20
LU91932I2 (fr) 2012-03-13
ES2282539T3 (es) 2007-10-16
JP2002509524A (ja) 2002-03-26
ATE238057T1 (de) 2003-05-15
PT956022E (pt) 2003-07-31
CN1239893A (zh) 1999-12-29
HK1210708A1 (en) 2016-05-06
HU227450B1 (en) 2011-06-28

Similar Documents

Publication Publication Date Title
HUP0001020A3 (en) Stanol composition and the use thereof
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
HK1019774A1 (en) Etching composition and use thereof.
HK1018780A1 (en) 6-Phenylpyridine-2-ylamine derivatives, the composition and use thereof.
ZA978178B (en) Composition.
GB9813271D0 (en) Composition and use
ZA975261B (en) Composition.
ZA200101933B (en) Novel composition and use
HK1033653A1 (en) Synergistic composition and use thereof
GB9717598D0 (en) Novel composition and use
ZA979011B (en) Hormonal composition and its use.
GB9608488D0 (en) Compositions, processes and uses
GB9608485D0 (en) Compositions, processes and uses
HUP0203721A3 (en) Novel hormonal composition and the use thereof
GB9608489D0 (en) Compositions, processes and uses
ZA9711047B (en) Formulation and use.
GB9608491D0 (en) Compositions, processes and uses
GB9706136D0 (en) Compositions,processes and uses
GB9718636D0 (en) Novel composition and use
GB9608493D0 (en) Compositions, processes and uses
GB9705849D0 (en) Compositions, processes and uses
GR3024722T3 (en) Copper-manganese-aluminium alloy and its use.
GB9706322D0 (en) Compositions, processes and uses
HK1051123A1 (en) Fungicidal and insectidical composition.
IL120481A0 (en) Combined enzyme composition and its use